Verified Nov 2026
Batteries & E-Mobility
·
Westminster, Colorado
·
Since 2001
Cerapedics Inc. is a medical device company headquartered in Westminster, Colorado, United States, founded in 2001. It has an estimated 200 to 500 employees and an estimated revenue band of $50 to 100 million. The company is privately held and develops osteobiologic products that support bone healing, repair, and fusion, serving orthopedics, spine surgery, and healthcare providers. In April 2026 it announced a supplier agreement with Vizient for its PearlMatrix P-15 peptide enhanced bone graft.
Cerapedics Inc. at a glance
Revenue
$50-100M
Est. band
Employees
200-500
Founded
2001
Headquarters
Westminster, Colorado
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
Cerapedics Inc. is a medical device company headquartered in Westminster, Colorado, United States, founded in 2001. It has an estimated 200 to 500 employees and an estimated revenue band of $50 to 100 million. The company is privately held and develops osteobiologic products that support bone healing, repair, and fusion, serving orthopedics, spine surgery, and healthcare providers. In April 2026 it announced a supplier agreement with Vizient for its PearlMatrix P-15 peptide enhanced bone graft.
At a glance
Attribute | Detail |
|---|---|
Founded | 2001 |
Headquarters | Westminster, Colorado |
Employees | 200-500 |
Revenue | $50-100M (estimated) |
Primary capability | Batteries & E-Mobility |
What Cerapedics Inc. makes
The company's products include the i-FACTOR Peptide Enhanced Bone Graft and PearlMatrix Bone Graft, which use proprietary P-15 peptide technology.
Products and capabilities described on the company's own site include Composite (source: cerapedics.com).
Latest developments
2026-04-27 — Cerapedics Enters Agreement with Vizient for PearlMatrix | ORTHOWORLD (orthoworld.com)
2026-04-27 — Cerapedics inks supplier agreement with Vizient for spinal bone graft - Becker’s Spine Review (beckersspine.com)
2026-04-24 — Cerapedics Announces Supplier Agreement with Vizient for PearlMatrix® P-15 Peptide Enhanced Bone Graft | Cerapedics Corporate (cerapedics.com)
2026-04-24 — News | Cerapedics Corporate (cerapedics.com)
2026-01-13 — Cerapedics' PearlMatrix P-15 Peptide Enhanced Bone Graft, The First and Only Proven Bone Growth Accelerator, Now Approved for Expanded Indications for Use (prnewswire.com)
2025-12-17 — Cerapedics Announces Publication in Spine of 24-Month ASPIRE Study Results of PearlMatrix™ P-15 Peptide Enhanced Bone Graft | Cerapedics Corporate (cerapedics.com)
Company details
PearlMatrix received expanded indications for use, announced in January 2026. Cerapedics Inc. was founded in 2001, has an estimated 200-500 employees, and is headquartered in Westminster, Colorado.
Frequently asked questions
What does Cerapedics Inc. make?
Cerapedics Inc. is a medical device company headquartered in Westminster, Colorado, United States, founded in 2001. It has an estimated 200 to 500 employees and an estimated revenue band of $50 to 100 million. The company is privately held and develops osteobiologic products that support bone healing, repair, and fusion, serving orthopedics, spine surgery, and healthcare providers. In April 2026 it announced a supplier agreement with Vizient for its PearlMatrix P-15 peptide enhanced bone graft.
Where is Cerapedics Inc. headquartered?
Cerapedics Inc. is headquartered in Westminster, Colorado (11025 Dover St, Westminster, Colorado, 80021).
When was Cerapedics Inc. founded?
Cerapedics Inc. was founded in 2001.
How big is Cerapedics Inc.?
Cerapedics Inc. has an estimated 200-500 employees, with revenue in the $50-100M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.